BioCentury | Sep 24, 2012
Company News

Elan management update

...Peter Hasler as COO, effective Oct. 1, while retiring as non-executive director, currently chairman of HBM BioVentures...
BioCentury | Sep 21, 2012
Company News

Elan names Hasler as COO

...but will retire from the board when he becomes COO. Hasler is currently chairman of HBM Bioventures...
BioCentury | Jul 30, 2012
Financial News

PTC completes venture financing

...completed: 7/23/12 Type: Venture financing Raised: $30 million Investors: Credit Suisse First Boston Private Equity; HBM BioVentures...
BioCentury | Jul 24, 2012
Financial News

PTC Therapeutics raises $30 million

...Plainfield, N.J.) raised $30 million from existing investors, including Credit Suisse First Boston Equity Partners; HBM BioVentures...
BioCentury | Jun 18, 2012
Finance

Fovista proves eye catching

...which has raised at least $66 million. Its syndicate includes Clarus Ventures; Novo A/S; and HBM BioVentures...
BioCentury | Jun 11, 2012
Finance

Tending the stable

...Tending the stable HBM BioVentures (SIX:HBMN) won't be making new investments this fiscal year, CEO Andreas Wicki...
...making sure that our most promising companies are fed well," Wicki said. About 42% of HBM BioVentures'...
...CHF35.8 million (6.6%). Pacira shares added 63% during HBM's fiscal year. Basilea shed 23%, but HBM BioVentures...
BioCentury | Feb 13, 2012
Finance

Calculating ChemoCentryx

...in the U.S. Investors include GSK (24.4% pre-IPO stake); Techne Corp. (19.7%); OrbiMed Advisors (11%); HBM BioVentures...
BioCentury | Jan 9, 2012
Financial News

Probiodrug completes venture financing

...Ventures; Edmond de Rothschild Investment Partners; LSP-Life Sciences Partners; Biogen Idec New Ventures; TVM Capital; HBM BioVentures...
BioCentury | Jan 5, 2012
Financial News

Probiodrug raises EUR 15 million

...Ventures; Edmond de Rothschild Investment Partners; LSP-Life Sciences Partners; Biogen Idec New Ventures; TVM Capital; HBM BioVentures...
BioCentury | Dec 5, 2011
Company News

Basilea infectious, dermatology news

...directors to the biotech's five-member board on Nov. 29 at a meeting requested by shareholder HBM BioVentures...
Items per page:
1 - 10 of 173
BioCentury | Sep 24, 2012
Company News

Elan management update

...Peter Hasler as COO, effective Oct. 1, while retiring as non-executive director, currently chairman of HBM BioVentures...
BioCentury | Sep 21, 2012
Company News

Elan names Hasler as COO

...but will retire from the board when he becomes COO. Hasler is currently chairman of HBM Bioventures...
BioCentury | Jul 30, 2012
Financial News

PTC completes venture financing

...completed: 7/23/12 Type: Venture financing Raised: $30 million Investors: Credit Suisse First Boston Private Equity; HBM BioVentures...
BioCentury | Jul 24, 2012
Financial News

PTC Therapeutics raises $30 million

...Plainfield, N.J.) raised $30 million from existing investors, including Credit Suisse First Boston Equity Partners; HBM BioVentures...
BioCentury | Jun 18, 2012
Finance

Fovista proves eye catching

...which has raised at least $66 million. Its syndicate includes Clarus Ventures; Novo A/S; and HBM BioVentures...
BioCentury | Jun 11, 2012
Finance

Tending the stable

...Tending the stable HBM BioVentures (SIX:HBMN) won't be making new investments this fiscal year, CEO Andreas Wicki...
...making sure that our most promising companies are fed well," Wicki said. About 42% of HBM BioVentures'...
...CHF35.8 million (6.6%). Pacira shares added 63% during HBM's fiscal year. Basilea shed 23%, but HBM BioVentures...
BioCentury | Feb 13, 2012
Finance

Calculating ChemoCentryx

...in the U.S. Investors include GSK (24.4% pre-IPO stake); Techne Corp. (19.7%); OrbiMed Advisors (11%); HBM BioVentures...
BioCentury | Jan 9, 2012
Financial News

Probiodrug completes venture financing

...Ventures; Edmond de Rothschild Investment Partners; LSP-Life Sciences Partners; Biogen Idec New Ventures; TVM Capital; HBM BioVentures...
BioCentury | Jan 5, 2012
Financial News

Probiodrug raises EUR 15 million

...Ventures; Edmond de Rothschild Investment Partners; LSP-Life Sciences Partners; Biogen Idec New Ventures; TVM Capital; HBM BioVentures...
BioCentury | Dec 5, 2011
Company News

Basilea infectious, dermatology news

...directors to the biotech's five-member board on Nov. 29 at a meeting requested by shareholder HBM BioVentures...
Items per page:
1 - 10 of 173